{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:09:57Z","timestamp":1792642197406,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"am","delay-in-days":328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.resinv.2024.07.011","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:48:33Z","timestamp":1722041313000},"page":"850-855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Selexipag for patients with pulmonary hypertension associated with lung disease: A preliminary study"],"prefix":"10.1016","volume":"62","author":[{"given":"Kazuya","family":"Yoshikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9163-9605","authenticated-orcid":false,"given":"Osamu","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kunita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusaku","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisako","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2024.07.011_bib1","first-page":"3618","article-title":"ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J 2022"},{"key":"10.1016\/j.resinv.2024.07.011_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1253\/circj.CJ-17-0139","article-title":"Effectiveness and outcome of pulmonary arterial hypertension-specific therapy in Japanese patients with pulmonary arterial hypertension","volume":"82","author":"Tamura","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.resinv.2024.07.011_bib3","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1183\/09031936.00078411","article-title":"ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre","volume":"39","author":"Hurdman","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.07.011_bib4","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1152\/jappl.1987.63.6.2460","article-title":"Alterations in hemodynamics and Kf,c during lung mass resection","volume":"63","author":"Townsley","year":"1987","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.resinv.2024.07.011_bib5","first-page":"980","article-title":"Lung perfusion scans and hemodynamics in acute and chronic pulmonary embolism","volume":"38","author":"Azarian","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1016\/j.resinv.2024.07.011_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1152\/physrev.00041.2010","article-title":"Hypoxic pulmonary vasoconstriction","volume":"92","author":"Sylvester","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1016\/j.resinv.2024.07.011_bib7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.201403-0446OC","article-title":"Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia","volume":"190","author":"Corte","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.07.011_bib8","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S2213-2600(19)30250-4","article-title":"Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study","volume":"7","author":"Nathan","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2024.07.011_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Galie","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.resinv.2024.07.011_bib11","first-page":"2737","article-title":"Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum 2013"},{"key":"10.1016\/j.resinv.2024.07.011_bib12","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2024.07.011_bib13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.07.011_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.resinv.2014.03.003","article-title":"Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values","volume":"52","author":"Kubota","year":"2014","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2024.07.011_bib15","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1164\/arrd.1987.135.6.1229","article-title":"Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease","volume":"135","author":"Mahler","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.resinv.2024.07.011_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.07.011_bib17","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1183\/20734735.0204-2019","article-title":"Oxygen devices and delivery systems","volume":"15","author":"Hardavella","year":"2019","journal-title":"Breathe"},{"key":"10.1016\/j.resinv.2024.07.011_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141911","article-title":"Pulmonary hypertension in patients with chronic fibrosing idiopathic interstitial pneumonias","volume":"10","author":"Hoeper","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2024.07.011_bib19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.chest.2016.08.002","article-title":"Pulmonary hypertension in diffuse parenchymal lung diseases","volume":"151","author":"Shlobin","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.07.011_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease","volume":"384","author":"Waxman","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2024.07.011_bib21","first-page":"81","article-title":"Sildenafil improves six-minute walk distance in chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial","volume":"53","author":"Rao","year":"2011","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"10.1016\/j.resinv.2024.07.011_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1753465808103499","article-title":"Effect of bosentan upon pulmonary hypertension in chronic obstructive pulmonary disease","volume":"3","author":"Valerio","year":"2009","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.resinv.2024.07.011_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S2213-2600(14)70013-X","article-title":"Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial","volume":"2","author":"Goudie","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2024.07.011_bib24","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.chest.2021.02.012","article-title":"Pulmonary hypertension in patients with COPD: results from the comparative, prospective registry of newly initiated therapies for pulmonary hypertension (COMPERA)","volume":"160","author":"Vizza","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.07.011_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1253\/circj.CJ-20-0939","article-title":"Multi-institutional prospective cohort study of patients with pulmonary hypertension associated with respiratory diseases","volume":"85","author":"Tanabe","year":"2021","journal-title":"Circ J"},{"key":"10.1016\/j.resinv.2024.07.011_bib26","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-158-9-201305070-00003","article-title":"Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial","volume":"158","author":"Raghu","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.resinv.2024.07.011_bib27","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1183\/09031936.00104612","article-title":"Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial","volume":"42","author":"Raghu","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.07.011_bib28","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021322","article-title":"The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease","volume":"350","author":"Celli","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2024.07.011_bib29","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.chest.2021.11.008","article-title":"Association of BMI and change in weight with mortality in patients with fibrotic interstitial lung disease","volume":"161","author":"Comes","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.07.011_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106933","article-title":"Outcome of patients who were incidentally diagnosed with idiopathic pulmonary fibrosis: how early in the disease should we identify patients?","volume":"201","author":"Yamazaki","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2024.07.011_bib31","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01914-2018","article-title":"Pulmonary hypertension in chronic lung disease and hypoxia","volume":"53","author":"Nathan","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.07.011_bib32","article-title":"Role of selexipag in chronic obstructive pulmonary disease (COPD) patients with out-of-proportion pulmonary hypertension","volume":"13","author":"Abuserewa","year":"2021","journal-title":"Cureus"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524001126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524001126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T03:58:06Z","timestamp":1732679886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534524001126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2212534524001126"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2024.07.011","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selexipag for patients with pulmonary hypertension associated with lung disease: A preliminary study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2024.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}